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Transplanted stem cells constitute a new therapeutic strategy for the treatment of 
neurological disorders. Emerging evidence indicates that a negative microenvironment, 
particularly one characterized by the acute inflamtion/immune response caused by 
physical injuries or transplanted stem cells, severely impacts the survival of 
transplanted stem cells. In our study, to avoid the influence of the increased 
inflammation following physical injuries, an intelligent, double-layer, alginate hydrogel 
system was designed. This system fosters the MMP secreted by transplanted stem cell 
reactions with MMP peptide grafted on the inner layer and destroys the structure of the 
inner hydrogel layer during the inflammatory storm. Meanwhile, the optimum 
concentration of the RGD peptide (which reportedly promotes stem cell proliferation 
and adhesion) is also immobilized to the inner hydrogels to obtain more stem cells 
before arriving to the outer hydrogel layer. We found that blocking Cripto-1, which 
promotes embryonic stem cell differentiation to dopamine neurons, also accelerates this 
process in neural stem cells. More interesting is the fact that neural stem cell 
differentiation can be conducted in astrocyte-differentiation medium without other 
treatments. In addition, the system can be adjusted according to the different parameters 
of transplanted stem cells and can expand on the clinical application of stem cells in the 
treatment of this neurological disorder. 
 
 
1. Introduction 
 
 
 
Parkinson’s disease (PD) is a neurodegenerative disorder caused by both the 
degeneration of dopamine (DA) neurons in the substantia nigra pars compacta (SNpc) 
and reduced DA levels in the striatum [1]. PD is an age-related disease that affects 2% 
of those aged 65 years and older, with 7–10 million individuals affected worldwide [2]. 
Patients with PD usually exhibit symptoms of resting tremor, bradykinesia, rigidity, 
postural instability and low dopamine level in the hypothalamus. The lack of dopamine 
will affect cognition and with the progression of the disease they gradually lose their 
self-care ability [3-5]. At present, pharmacological treatments only provide 
symptomatic relief with no abatement or reversal of disease progression [6, 7]. Stem 
cell-based therapies have emerged as treatment options to repair neurological disorders, 
but they have been difficult to translate clinically [8, 9]. Since the efficacy of cell 
therapies has been limited given the low rates of cell survival, which results from the 
influence of the acute inflammation/immune response caused by transplantation and the 
lack of support from the extracellular matrix, transplanted cells usually die in the first 
several days after transplantation. In addition, the limited differentiation still restricts 
the therapeutic effect of cell therapy, as only 5% of the surviving neural stem cells 
(NSCs) transplanted to the damaged sites differentiate into neurons in vivo without any 
treatment [10-13]. As such, novel approaches for stem cell transplantation need to be 
developed. 
The use of biomaterials, especially hydrogels, can create permissive 
microenvironments to enhance stem cell engraftment and treatment efficiency [13-15]. 
Several types of biomaterials have been investigated in recent years as scaffolds for the 
three-dimensional (3D) culture and differentiation of pluripotent cells [16-18]. Alginate 
is a natural polymer that is derived from algae and composed of (1-4)-linked b-D- 
mannuronic acid and a-L-guluronic acid; it is commonly used as 3D scaffold 
biomaterials. Unmodified alginate can be molded into different mechanical properties 
using divalent cations such as Ca2+ for ionic crosslinking, which can create simple and 
efficient scaffold-fabrication and cell-encapsulation processes [19]. 
Alginate-supported cultures have been tested and can be used in the proliferation 
and differentiation of various pluripotent cells both in vitro and in vivo [18, 20, 21]. A 
recent study showed that the use of alginate hydrogels for cell transplantation and the 
release of neurotrophic factors can promote axonal regeneration in the injured spinal 
cords of rats [22]. Many studies show that unmodified alginate does not provide 
adequate cell adhesion. Alginate can be modified to improve cell attachment and 
motility. Several reports have indicated that RGD (the tripeptide motif found in several 
ECM proteins)-containing peptides promote NSC adhesion when coupled to polymer 
surfaces [23, 24]. Thus, in our study, an appropriate concentration of the RGD 
polypeptide was grafted to the alginate, which was used to enhance the survival of the 
transplanted NSCs. Furthermore, some studies showed that blocking the expression of 
Cripto-1, an epidermal growth factor (EGF)-CFC family member that plays a role in 
embryogenesis, can improve the differentiation of embryonic stem cell (ESC)-derived 
dopaminergic neurons in vitro and foster their engraftment in vivo [25, 26]. However, 
there is no evidence to suggest the roles of Cripto-1 in the differentiation of NSCs; as 
such, we intend to explore whether blocking Cripto-1 in NSCs achieves the same effect 
as is observed in ESCs in our research. Mounting evidence suggests that the properties 
of hydrogels, such as their mechanical stability and elastic modulus, strongly influence 
the cell phenotype, except for the fact that the alginate hydrogel possesses an elastic 
modulus that is comparable to that of brain tissue and can promote NSC differentiation 
and proliferation [27-30]. Alginate hydrogels, which have suitable mechanical 
properties that can benefit NSC proliferation or differentiation, were designed and an 
intelligent hydrogel system was subsequently constructed for transplanted NSCs. 
To achieve better therapeutic effects, the acute inflammatory/immune response 
caused by transplantation should be considered in addition to improving the survival 
and differentiation rate of transplanted NSCs. In our study, to avoid the influence of 
high levels of inflammation following NSC transplantation to the damaged site, 
intelligent, double-layer, alginate hydrogels were designed. High-concentration (1.5%) 
alginate can inhibit NSC differentiation; here, it was immobilized with RGD and MMP 
substrate peptides to form the core layer of the alginate hydrogel. The outer layer of the 
alginate hydrogel was constituted by low-concentration alginate (1%), which can form 
a dense network and is immobilized with the Cripto-1 antibody to promote the 
differentiation of transplanted NSCs. During acute inflammatory period after physical 
injuries, the double layer of alginate can protect the NSCs from injury and the NSCs 
which surrounded by the core layer alginate hydrogel subsequently secrete MMP, which 
interacts with the MMP substrate to destroy the structure of the inner hydrogel. When 
the peak inflammation ends, the NSCs are released into the outer hydrogel layer and the 
Cripto-1 antibody is immobilized on the outer layer to enhance the NSCs, which are 
then differentiated into dopaminergic neurons, thus promoting the recovery of 
injured nerves. 
 
2. Materials and methods 
 
2.1. Cell lines and materials 
 
The strain C57BL/6 mouse NSCs which were purchased from Cyagen Biosciences Inc. 
(Guangzhou, People’s Republic of China) are derived from the hippocampi and 
subventricular zones (SVZ) of day 12.5 post coitus C57BL/6 embryos and cultured as 
neurospheres in Strain C57BL/6 Mouse Neural Stem Cell Growth Medium (which 
contains B-27 supplement, basic fibroblast growth factor [bFGF], epidermal growth 
factor [EGF], GlutaMAXTM supplement, and heparin sodium) also were purchased from 
Cyagen Biosciences Inc. (Guangzhou, People’s Republic of China). The 2B11 
hybridoma cells, which can secrete the Cripto-1 antibody, were purchased from the 
Biosynthesis Biotechnology Company (Beijing, People’s Republic of China). 
Dulbecco's Modified Eagle’s Medium, Nutrient Mixture F-12 (DMEM/F-12), N-2 
supplement, and fetal bovine serum (FBS) were purchased from Thermo Fisher 
Scientific (Waltham, MA, USA). Propidium iodide (PI), calcein, phalloidin, and 4,6- 
diamidino-2-phenylindole (DAPI) were purchased from Sigma-Aldrich Co. (St. Louis, 
MO, USA). Mouse monoclonal βIII-tubulin, PITX3, GIRK2, and GFAP primary 
antibodies, as well as FITC-conjugated goat polyclonal secondary antibodies to rabbit 
immunoglobulin (Ig)G, and rhodamine-conjugated rat polyclonal secondary antibodies 
to rabbit IgG were purchased from Abcam plc (Cambridge, MA, USA). 
2.2. Experimental animals 
Sprague–Dawley rats, 6–8 weeks of age, were provided by the Laboratory Animal 
Center of Harbin Medical University. All animals were fed ad libitum and kept under a 
normal 12-hour light/12-hour dark cycle. All procedures were approved by the 
University Ethics Committee of the Harbin Institute of Technology. 
 
 
2.3. Synthesis of the inner and cover alginate hydrogel-grafted RGD and MMP 
polypeptide or immobilized Cripto-1-blocking antibody and its physicochemical 
characterization 
The oxidized alginate was obtained by mixing sodium peroxide and sodium alginate (in 
distilled water) with a mass ratio of 1:2. The reaction was conducted at 4°C for 2 hours 
and was terminated by the addition of ethylene glycol; the degree of oxidation was 
evaluated by measuring the concentration of sodium peroxide, which was maintained 
after 2 hours. Then, the oxidized alginate was lyophilized at –20°C and dissolved in 
distilled water to achieve a concentration of 1.5% for inner alginate and 1% for cover 
alginate. The RGD- and MMP-grafted inner alginate and Cripto-1 antibody- 
immobilized cover alginate were prepared by dissolving different concentrations of 
RGD or MMP polypeptide and Cripto-1 antibody in an oxidized alginate solution while 
stirring. The RGD and MMP polypeptide-grafted inner alginate and Cripto-1 antibody- 
immobilized cover alginate were collected and lyophilized at –20°C. The alginate 
hydrogel was prepared by crosslinking with calcium ions. The gelation process and the 
mechanical properties of the alginate hydrogels were evaluated by examining the time 
of gelation onset and the evolution of elasticity at 37°C in constant strain mode by 
means of a Bohlin Gemini II rheometer (Malvern Instruments, Malvern, UK) using 
parallel plate geometry (40 mm in diameter), as in our previous study [31]. 
 
 
2.4 Preparation of the intelligent double-layer alginate hydrogel system 
 
Briefly, the 1.5% alginate solution that grafted the RGD and MMP polypeptide was 
added to 100 mM of CaCl2 solution to obtain calcium alginate gel beads. After 
hardening for 10 minutes, the beads were dipped into 1% (w/v) chitosan solution to 
form an alginate–chitosan membrane around the surface. Then, the microcapsules were 
rinsed by saline to remove the excess chitosan and were transferred to the 1% alginate 
solution, which immobilized the Cripto-1 antibody. Finally, the microcapsules were 
cleaned with saline a second time and added to the 100 mM CaCl2 solution for 10 
minutes to form the alginate/chitosan/alginate microcapsules. 
 
 
2.5. Cell culture and seeding on hydrogels 
 
The NSCs of mice were grown in NSC growth medium and incubated in a humidified 
atmosphere of 5% CO2 at 37°C, with media changes every other day. The NSCs were 
digested after centrifugation and seeded onto the cover alginate hydrogel, which 
immobilized the Cripto-1 antibody; the cells were then incubated in a humidified 
atmosphere of 5% CO2 at 37°C and grown in astrocyte-favorite media supplemented 
with 1% FBS, 1% GlutaMAXTM , 1% penicillin–streptomycin, and 1% N-2. For the 
inner alginate grafted with the RGD and MMP polypeptides, the NSCs were seeded on 
and grown in the NSC growth medium which were prepared with neural stem cell basal 
medium supplement with 2% B27, 20ng/ml bFGF, 20ng/ml EGF and 50ng/ml heparin 
sodium and incubated in a humidified atmosphere of 5% CO2 at 37°C. 
2.6. Scanning electron microscopy 
 
Cell clones were released from our developed screening platform and they were fixed 
with 2.5% glutaraldehyde for 30 minutes at 37°C, followed by overnight incubation in 
0.1 M sodium cacodylate buffer containing 2.5% glutaraldehyde at 4°C. After 
dehydration by serial washing twice in each increasing ethanol concentration (0%, 30%, 
50%, 70%, 85%, 95%, and 100%), the samples were critical point dried, sectioned, 
mounted, and sputter coated with platinum before imaging with a JSM-7000 scanning 
electron microscope (SEM) (JEOL, Tokyo, Japan). 
2.7. qRT-PCR assay 
 
 
Total RNA was extracted by Trizol, cDNA was prepared according to RNA, and 
FastStart Universal SYBR Green Master (Rox) and the ABI Prism 7500 sequence 
detection system were used to complete the RT-PCR: 50°C, 2 minutes; 95°C 
predegeneration, 10 minutes; 95°C, 15 seconds; 60°C, 60 seconds. This was done for a 
total of 40 cycles and each sample had three repeats; the 2-ΔΔCt method was used for 
conversion. The following table shows the primer sequences used in the study. 
Gene 5’ primer 3’ primer 
Mus GAPDH TGGCCTTCCGTTCCTAC GAGTTGCTGTTGAAGTCGCA 
Mus GFAP GGAGAGGGACAACTTTGCAC CCAGCGATTCAACCTTTCTC 
βIII-tubulin TTCTGGTGGACTTGGAACCT ACTCTTTCCGCACGACATCT 
 
 
 
 
Mus TH TCAGAGCAGGATACCAAGCA CGAATACCACAGCCTCCAA 
 
 
 
 
 
2.8. Immunofluorescence analysis 
 
Following 3D culture in AbCripto-1 hydrogel microbeads for 14 days, 4% 
paraformaldehyde was used to fix the samples; then, 1% TritonX-100 0.9% NaCl was 
used to permeabilize the cytomembrane when the intracellular protein was tested. After 
fixation for 1 hour or permeabilization for 30 minutes, 0.9% NaCl was used to wash the 
sample three times, at 5 minutes each. Cell markers were used to identify the different 
cell types: βIII–Tubulin was used for neurons, GFAP for astrocytes, Nurr 1 and TH for 
dopaminergic neurons, and PITX-3 and GIRK-2 for A9 dopaminergic neurons. NSCs 
were transfected with green fluorescent protein (GFP) to emit green; these markers were 
used in combination with the red fluorescent antibody. Following the staining reaction, 
0.9% NaCl was used to wash the sample three times, 5 minutes each. Every step was 
carefully treated to not break the hydrogel structure. 
 
2.9. Statistical Analysis 
 
The results are presented as the mean ± standard deviation. Student’s two-tailed t-test 
was performed to compare the differences between the experimental and control groups. 
A P-value <0.05(*) was considered significant, while a P-value <0.01 (**) was 
considered very significant. 
 
 
3. Results 
 
3.1 Exploration of the optimum conditions used to build the intelligent double-layer 
alginate hydrogel system 
One of the key issues with stem cell transplantation is ensuring cell survival, as only a 
small percentage of transplanted cells can survive several days after transplantation. 
Recent work has revealed that the acute inflammatory/immune response, oxidative 
stress, and other processes that result from injury or transplantation are likely to result 
in cell death [32-34]. In our study, we aimed to establish an intelligent, double-layer, 
alginate hydrogel system where NSCs can proliferate in the inner layer, while the outer 
material was used to block the inflammatory storm. By the end of the inflammatory 
storm, the NSCs arrived at the outer layer through secreting MMP to slice the MMP 
polypeptide grafted on the inner layer. We also designed the intelligent, double-layer, 
alginate hydrogel system for PD treatment, so we immobilized the Cripto-1 antibody to 
the outer alginate, which reportedly improves the differentiation of ESC-derived 
dopaminergic neurons in vitro and their engraftment in vivo. In this way, the optimal 
conditions for the development of an intelligent, double-layer, alginate hydrogel system 
were explored in our research (Fig. 1). 
3.2 Effect of the hydrogel-immobilized Cripto-1 antibody on the neuronal 
differentiation of NSCs 
Considerable evidence indicates that the blocking of Cripto-1 can promote the 
differentiation of ESCs to DA neurons in vitro and in vivo [25]. however, no research 
has reported on the differentiation of NSCs to DA neurons by blocking Cripto-1. In our 
study, different concentrations of the Cripto-1-blocking antibody (0 μg/mL, 20 μg/mL, 
and 100 μg/mL) were immobilized on the partial oxidation of sodium alginate. The 
calcium crosslinked, alginate-composite hydrogel was developed by mixing the 
alginate-immobilized Cripto-1 antibody and cell suspension at a volume ratio of   1:1; 
the NSCs were then wrapped inside and cultured in astrocyte-differentiation medium, 
which mimics the microenvironment for NSC differentiation in vivo. This was done to 
investigate whether blocking Cripto-1 can promote NSC differentiation to DA neurons. 
Normally, 90% of NSCs will differentiate into astrocytes in astrocyte-differentiation 
medium without any other treatment. Interestingly, after 14 days of culture in our 
alginate-composite hydrogel-immobilized Cripto-1 antibody with different 
concentrations, we observed significant changes in the cell morphology of cultured 
NSCs. As shown in Fig. 2, the typical morphology of astrocytes can only be seen in the 
encapsulated cells in 0 μg/mL of the AbCripto-1 hydrogel. Further, the slender cell- 
shaped component network can be observed in the hydrogel with both low and high 
concentrations of immobilized Cripto-1 antibody. SEM was used to further study the 
cell morphology changes. AbCripto-1-immobilized, hydrogel-cultured NSCs longed 
out of the synapse and presented typical neuron morphology (Fig. 2). Although the cell 
morphology exhibited typical changes, additional verification and support are needed 
through numerous experiments to demonstrate how blocking Cripto-1 can promote 
NSC differentiation to neurons. 
 
To further verify that the neural differentiation of NSCs occurred after blocking Cripto- 
1, we performed molecular analyses at day 14 of culture (D14); at this time, cells were 
released from the alginate microcapsules by sodium citrate, and RNA was collected for 
quantitative real-time reverse transcription (qRT-PCR) analysis. Moreover, some 
alginate microcapsules were fixed directly for immunocytochemistry. As shown in Fig. 
3, after 14 days of being cultured in astrocyte-differentiation medium, the cells were 
negative for pluripotent markers OCT4 and NANOG (data not shown), but in the 
AbCripto-1-immobilized hydrogel, neural differentiation occurred, as evidenced by the 
significantly reduced expression of GFAP – a marker of astrocyte differentiation. In 
contrast, the neuron marker (βIII-tubulin) and dopaminergic neuron markers (Nurr1 and 
TH) were significantly higher in the AbCripto-1-immobilized, hydrogel-cultured NSCs 
when compared with controls. In addition, βIII-tubulin and Nurr1/DAT1 expression 
was determined by immunofluorescence, and the results were consistent with those 
found for qRT-PCR; the NSCs cultured in the hydrogel-immobilized, Cripto-1 antibody 
showed a faster progression toward neuronal differentiation with positive expression 
when compared to the control, where none of the Cripto-1 antibodies were immobilized 
(Fig. 4 and Supplementary Fig. 1). The progressive degeneration of A9 dopaminergic 
neurons is regarded as the major cause of PD. To determine whether blocking Cripto-1 
in the NSCs can induce A9 dopaminergic differentiation, the PITX-3/GIRK2 protein – 
which is responsible for the characteristics of A9 dopaminergic neurons – was detected 
by immunofluorescence analysis (Supplementary Fig. 1). When blocking Cripto-1 in 
the NSCs by culturing these cells in the AbCripto-1-immobilized hydrogels, it was 
possible to enable NSC differentiation into A9 dopaminergic neurons, and the 
efficiency of NSC differentiation tended to increase with increasing concentrations of 
the grafted Cripto-1 antibody. As shown in Supplementary Fig. 2, approximately 56% 
of cells were Nurr1 positive, as they were cultured in the highest concentration of the 
AbCripto-1 grafted hydrogel; this rate was significantly higher than that of the control 
group, as analyzed by flow cytometry. To further characterize the extent to which the 
cells had differentiated, and to identify the morphology of the differentiated cells, 
immunofluorescence staining with Nurr1 and GIRK2 antibodies was used to   observe 
the clear neural network in a 3D reconstruction, as viewed by confocal microscopy 
(Supplementary Fig. 3). Taken together, these data suggest that blocking the Cripto-1 
antibody in NSCs cultured in hydrogel not only prevented NSC differentiation in 
astrocytes in astrocyte-favorite medium, but it also promoted the differentiation of most 
stem cells into dopaminergic neurons. 
3.3 Exploring the optimal concentration of grafted RGD and MMP polypeptides for 
NSC proliferation and migration in core layer hydrogel materials 
 
The importance of time-dependent changes in the microenvironment of injured or 
transplanted areas in regulating transplanted stem cell survival and differentiation is 
becoming increasingly evident. As is well known, the inflammatory storm that results 
from injury or transplantation is one of the primary factors that induce transplanted stem 
cell death. Several studies have shown that MMPs, which are secreted by NSCs and the 
RGD peptide, play important roles in the proliferation, migration, and adhesion of 
NSCs. The oxidation of sodium alginate, which is used to synthesize the inner hydrogel 
layer in our study, can produced aldehyde groups that form unstable amines found 
within the free amino peptide groups; thus, we covalently linked the MMP and RGD 
peptide to the alginate polymer chain. The inner alginate hydrogel was prepared by the 
gelation of oxidation alginate grafted different concentration RGD peptide with Ca2+. 
The Live/Dead assay was used to detect the influence of the different concentrations of 
RGD on the proliferation and survival of NSCs. As shown in Fig. 5, 50 μg/mL of grafted 
RGD promoted the survival and proliferation of NSCs cultured in the alginate hydrogel. 
Further,  to  culture  the  NSCs  in  the  inner  hydrogel  layer,  so  as  to  escape      the 
inflammatory storm, we decided to choose the optimal concentration of MMP peptide 
to graft to the hydrogel. We prepared alginate hydrogels grafted with different 
concentrations of MMP (10 μg/mL, 60 μg/mL, and 100μg/mL) and cultured the NSCs 
in the hydrogel. As shown in Fig. 6, we found that the 60 μg/mL concentration yielded 
the best results, insofar as the highest number of NSCs migrated out the hydrogel after 
12 days of culture. 
3.4 A tentative study of the differentiation effectiveness of this intelligent double-layer 
alginate hydrogel system for NSCs transplantation in vivo 
While the NSCs cultured in our alginate hydrogel system can yield better differentiation 
effects by mimicking the intracorporeal environment through cultured the NSCs in 
astrocyte-differentiation medium, further validation is required in vivo due to the 
complicated microenvironment of brain internal. Therefore, in our study, a rat brain 
trauma model was prepared by creating two symmetrical, 5 mm × 5 mm wounds on the 
left and right side of the rat brain. The left wound was transplanted with NSCs 
containing 0 μg/mL of AbCripto-1 hydrogel, while the right wound was transplanted 
with NSCs containing 50 μg/mL of AbCripto-1 hydrogel. Fourteen days after 
transplantation, the rats were sacrificed and their brains were submitted for section and 
immunofluorescence staining. As shown in Fig. 7, our alginate hydrogel system- 
immobilized Cripto-1 antibody can promote the survival and differentiation of NSCs 
transplanted in vivo. 
4. Discussion 
 
 
Numerous studies have demonstrated that stem cell-based therapies have therapeutic 
efficacy against neurological disorders [10, 11, 35-37]. Due to the low survival   rates 
and reduced differentiation efficiency following stem cell transplantation, the 
therapeutic effects toward neurological disorders is minimal [37-39]. Recent work has 
revealed that the use of hydrogels (a class of biomaterials), which are composed of 
water-swollen polymeric networks, can improve stem cell engraftment and function [15, 
40]. It is known that hydrogels provide support to the extracellular matrix during stem 
cell transplantation, offering benefits to cell retention and survival [21]. As such, in our 
study, a non-toxic and low-immunogenicity alginate hydrogel was used. Several studies 
have shown that alginate creates excellent, flexible scaffolds for stem cells transplanted 
in different animal species [41-43]. Although lots of alginate hydrogel systems have 
been developed for stem cell transplantation and have achieved good results in vitro and 
in vivo, it is generally difficult to use them in the clinical treatment of neurological 
disorders [22, 24, 40]. There is now overwhelming evidence to support the idea that 
changes in the microenvironments over time affect stem cell survival and the therapeutic 
potential of stem cell transplantation in the treatment of central nervous system trauma 
and neurodegenerative diseases [32]. The acute inflammatory/immune response, as well 
as some negative factors caused by transplant surgery or transplanted stem cells, also 
severely impact the survival of transplanted stem cells [33, 34]. To address this clinical 
issue, the establishment of an efficient and available hydrogel system used for stem cell 
transplantation remains a challenge in the treatment of neurological disorders. In our 
study, we developed an intelligent, double-layer, alginate hydrogel system that contained 
an inner layer comprised of alginate hydrogel-grafted MMP and RGD polypeptides, and 
an outer layer of alginate hydrogel-grafted Cripto-1 
antibodies. The transplanted stem cells that proliferated in the inner hydrogel can 
secrete MMP enzymes while slicing the grafted MMP polypeptides and breaking 
through the inner materials; the cells then moved to the outer hydrogel layer following 
the inflammatory storm that resulted from damage or surgery. In the present study, it 
was observed that the optimal concentration of the MMP peptide enabled the stem cells 
to move to the outer hydrogel layers, while avoiding the inflammatory storm. At the 
same time, the optimal concentration of the RGD peptide, which was shown to be good 
for the adhesion and proliferation of NSCs, was grafted to the inner hydrogel to promote 
the proliferation of stem cells encapsulated in the inner hydrogel [44]. 
When examining stem cell-based therapies for neurological disorders, researchers tend 
to choose ESCs or induced pluripotent stem cells (iPSCs), and these cells can usually 
obtain good outcomes when treating neurological disorders in vitro and in vivo [39]. 
However, the application of ESC or iPSC transplantation in the treatment of 
neurological diseases is also associated with the inevitable risks of teratoma 
development [11, 45]. Many researchers have proved that reducing the risk of teratoma 
development, as induced by stem cell transplantation, can be achieved by regulating the 
signaling pathway or engaging in molecular therapy, while other studies have 
successfully reduced the probability of teratoma development, but there are still some 
related safety concerns [46]. To avoid the generation of teratomas during treatment, we 
chose NSCs for this study. Furthermore, considerable evidence indicates that the 
material properties of hydrogels are important in the stem cell proliferation and 
differentiation [16, 29, 30]. Research has shown that a 1% concentration of alginate 
hydrogel which present elastic modulus in the range of soft substrates (100-1000pa) 
promotes NSC differentiation, while a 1.5% concentration which more stiffer inhibits 
NSC differentiation and accelerates NSC proliferation [27, 43]. Thus, in our study, the 
inner and outer alginate hydrogel concentrations were 1.5% and 1%, respectively. 
It has been reported that blocking Cripto-1 in ESCs facilitates their differentiation to 
dopaminergic neurons, while significantly reducing the incidence of teratoma 
formation; however, it was also found that teratomas were still observed in as many as 
27% of the grafted rats [25]. In our study, Cripto-1 in NSCs was blocked by grafting 
the Cripto-1 antibody to the hydrogel. We noticed an interesting phenomenon when 
culturing the cells in astrocyte differentiation medium: the NSCs cultured in our 
hydrogel system showed progressive neuronal differentiation with extensive neurite 
formation. Additionally, cells cultured on our hydrogel system displayed increased 
expression of the dopaminergic neuron-related genes such as PITX-3 and GIRK2. The 
degeneration of dopamine neurons has become the leading cause of PD. As such, our 
study provides a novel approach in the treatment of PD through NSC transplantation. 
Although the overall approach adopted in this study focused on studying NSCs, these 
intelligent, double-layer, alginate hydrogels were designed to easily adapt to other types 
of transplanted stem cells. Therefore, we anticipate that these double-layer alginate 
hydrogels can be used for stem cell-based therapies in the clinical treatment of 
neurological disorders. 
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 Figure 1.The scheme to show the use of our intelligent, double-layer, alginate hydrogel for NSCs 
transplantation to achieve better therapeutic effect for PD treatment. 
 
 
 
Fig. 2. Morphology observation of NSCs cultured in alginate hydrogel immobilized with different 
concentrations of AbCripto-1. The typical morphology of astrocytes was evident in the hydrogels, 
which immobilized 0 μg/mL of AbCripto-1 (a); the slender cell-shaped component network was 
found in the alginate hydrogel, which immobilized 10 μg/mL or 50 μg/mL of AbCripto-1 (b, c, d). 
Scanning electron microscope image of differentiated cells cultured with 50 μg/mL of AbCripto-1 
hydrogel (e, f, g, h). 
 
 
 
 
Fig. 3. RT-qPCR analyses on glial marker(GFAP), neural differentiation markers (bIII-tubulin) and dopaminergic 
neuron markers (Nurr1 and TH) at D14. 
 
 
Fig. 4. Immunocytochemistry analyses at D14 for the early neural differentiation marker, βIII- 
tubulin, in red. 
 
 
 
 
Fig. 5. Effect of different concentration of RGD immobilization on NSC proliferation. 
 
 
Fig. 6. Effect of MMP immobilization on NSC migration. The number of NSCs migrated 
beyond the inner layer hydrogel with the extending of incubation time (a, c). The expression of 
MMP protein in NSCs (b). 
 
 
Fig. 7. The differentiation of transplanted NSCs through our intelligent, double-layer, alginate 
hydrogel system in vivo. 
 
 
Supplementary Fig. 1 Immunocytochemistry analyses at D14 for the A9 dopaminergic 
differentiation marker, the PITX-3/GIRK2, in red . 
 
 
 
 
Supplementary Fig. 2 Flow cytometric examination the differentiation rate of the NSCs cultured in 
alginate hydrogel with different concentration Cripto-1 antibody immobilized. 
Supplementary Fig. 3 The 3D reconstruction of the neural network formed by the differentiation 
of NSCs cultured in our alginate hydrogel with Cripto-1 antibody immobilized. 
 
 
 
